Low-level Laser Therapy on Oral Pemphigus Vulgaris Patients.
Launched by CAIRO UNIVERSITY · May 10, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a treatment called low-level laser therapy for patients who have a condition known as oral pemphigus vulgaris. This condition causes painful sores in the mouth and can be quite uncomfortable. The goal of the study is to see if this type of laser therapy can help improve the symptoms for these patients.
To participate in the trial, individuals need to be diagnosed with oral pemphigus vulgaris. Unfortunately, those who have other reasons for mouth sores won’t be eligible. The trial is not yet recruiting participants, but once it starts, those involved can expect to receive the low-level laser treatment and will be monitored to see how effective it is in relieving their symptoms. This study aims to provide new options for managing this challenging condition.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with oral pemphigus vulgaris
- Exclusion Criteria:
- • other causes of oral ulcers
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported